UBS Group’s Advanced Biomed Inc ADVB Stock Holding History

UBS Group’s Portfolio ADVB Stock Details ADVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-216	Closed	-$1.26K	–	11537
2025 Q4	$1.26K	Buy	216 +48	+29%	+$401	﹤0.01%	9646
2025 Q3	$1.5K	Sell	168 -1,073	-86%	-$11.1K	﹤0.01%	9333
2025 Q2	$17.4K	Buy	+1,241	New	+$36.6K	﹤0.01%	8530

UBS Group's ADVB Position: Q1 2026 in Review

UBS Group sold out of Advanced Biomed Inc (ADVB) in Q1 2026, closing a stake of 216 shares — an estimated $1.26K sold.

UBS Group first reported a position in ADVB in Q2 2025 and held it in 3 quarters. The position peaked at $17.4K in Q2 2025. 0 funds tracked by Wall St. Rank hold ADVB as of Q1 2026.

UBS Group reported no remaining Advanced Biomed Inc position as of Q1 2026 after selling out during the quarter.
UBS Group sold 216 Advanced Biomed Inc shares in Q1 2026, an estimated $1.26K.
UBS Group first reported a position in Advanced Biomed Inc in Q2 2025 and held it in 3 quarters.
UBS Group's Advanced Biomed Inc position peaked at $17.4K in Q2 2025.
0 funds tracked by Wall St. Rank held Advanced Biomed Inc as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.